GT Apeiron Therapeutics Strengthens Advisory Board
GT Apeiron Therapeutics Strengthens Advisory Board News provided by Share this article Share this article SHANGHAI, April 15, 2021 /PRNewswire/ -- Keith Lenden and Dr. Honggang Bi has been appointed as new members of the Advisory Board at GT Apeiron Therapeutics, an AI empowered drug discovery start-up developing oncology therapeutics. Mr. Lenden and Dr. Bi add further expertise in drug discovery innovation, translational medicine, and clinical development; and deep knowledge and perspectives ...
United States Smithkline Beecham Keith Lenden Prnewswire Keith Lenden Drug Development Head Company Advisory Board
Source: prnewswire.com